Table 5 Event rates in patients with and without cancer
All patients | Pts with cancer at admission | Pts without cancer at admission | OR (95%CI) | p-value* | ||
|---|---|---|---|---|---|---|
n/avail. | % | n/avail. | % | |||
Thromboembolic events | ||||||
Combined endpoint | 12/227 | 5.29 | 104/2516 | 4.13 | 1.29 (0.70-2.39) | 0.4097 |
Proximal DVT | 10/225 | 4.44 | 98/2516 | 3.90 | 1.15 (0.59-2.23) | 0.6851 |
Symptomatic non-fatal PE | 1/257 | 0.39 | 9/2827 | 0.32 | 1.22 (0.15-9.69) | 0.8488 |
VTE related death | 1/263 | 0.38 | 0/2852 | 0 | - | - |
Distal DVT | 17/207 | 8.21 | 178/2270 | 7.84 | 1.05 (0.63-1.77) | 0.8495 |
Proximal or distal DVT | 21/207 | 10.14 | 218/2280 | 9.56 | 1.07 (0.67-1.71) | 0.7851 |
Symptomatic DVT | 2/253 | 0.79 | 7/2814 | 0.25 | 3.20 (0.66-15.46) | 0.1488 |
Death from any cause | 8/263 | 3.04 | 33/2852 | 1.16 | 2.68 (1.22-5.86) | 0.0136 |